Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: E9AFX0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 119 | 121 | PF00675 | 0.614 |
CLV_NRD_NRD_1 | 124 | 126 | PF00675 | 0.618 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.686 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.437 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.680 |
CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.429 |
CLV_PCSK_PC1ET2_1 | 140 | 142 | PF00082 | 0.668 |
CLV_PCSK_PC1ET2_1 | 175 | 177 | PF00082 | 0.429 |
CLV_PCSK_PC7_1 | 136 | 142 | PF00082 | 0.713 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.620 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.408 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.468 |
DEG_APCC_DBOX_1 | 124 | 132 | PF00400 | 0.428 |
DEG_APCC_DBOX_1 | 175 | 183 | PF00400 | 0.495 |
DOC_USP7_MATH_1 | 139 | 143 | PF00917 | 0.449 |
DOC_USP7_MATH_1 | 197 | 201 | PF00917 | 0.596 |
DOC_WW_Pin1_4 | 52 | 57 | PF00397 | 0.654 |
LIG_deltaCOP1_diTrp_1 | 73 | 78 | PF00928 | 0.487 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.554 |
LIG_LIR_Nem_3 | 34 | 39 | PF02991 | 0.202 |
LIG_LIR_Nem_3 | 73 | 78 | PF02991 | 0.469 |
LIG_LIR_Nem_3 | 95 | 99 | PF02991 | 0.347 |
LIG_PDZ_Class_2 | 203 | 208 | PF00595 | 0.556 |
LIG_Pex14_2 | 152 | 156 | PF04695 | 0.414 |
LIG_SH2_CRK | 36 | 40 | PF00017 | 0.415 |
LIG_SH2_PTP2 | 96 | 99 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.465 |
LIG_SH2_STAT5 | 171 | 174 | PF00017 | 0.279 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.346 |
LIG_SH3_3 | 141 | 147 | PF00018 | 0.520 |
LIG_SxIP_EBH_1 | 124 | 133 | PF03271 | 0.408 |
LIG_WRC_WIRS_1 | 153 | 158 | PF05994 | 0.347 |
MOD_CK1_1 | 201 | 207 | PF00069 | 0.561 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.635 |
MOD_Cter_Amidation | 185 | 188 | PF01082 | 0.436 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.450 |
MOD_GlcNHglycan | 191 | 195 | PF01048 | 0.492 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.644 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.372 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.484 |
MOD_GSK3_1 | 197 | 204 | PF00069 | 0.661 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.378 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.668 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.600 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.219 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.336 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.415 |
MOD_PIKK_1 | 76 | 82 | PF00454 | 0.279 |
MOD_Plk_1 | 201 | 207 | PF00069 | 0.530 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.437 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.183 |
MOD_ProDKin_1 | 52 | 58 | PF00069 | 0.649 |
TRG_DiLeu_BaLyEn_6 | 156 | 161 | PF01217 | 0.312 |
TRG_ENDOCYTIC_2 | 27 | 30 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 96 | 99 | PF00928 | 0.346 |
TRG_ER_diArg_1 | 141 | 144 | PF00400 | 0.448 |
TRG_NLS_Bipartite_1 | 125 | 144 | PF00514 | 0.405 |
TRG_NLS_MonoCore_2 | 144 | 149 | PF00514 | 0.443 |
TRG_NLS_MonoExtN_4 | 139 | 144 | PF00514 | 0.421 |
TRG_Pf-PMV_PEXEL_1 | 187 | 191 | PF00026 | 0.426 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2X3 | Leptomonas seymouri | 74% | 72% |
A0A0S4J7P3 | Bodo saltans | 31% | 69% |
A0A0S4J8A4 | Bodo saltans | 30% | 69% |
A0A3Q8IVL9 | Leishmania donovani | 93% | 100% |
A4HNF9 | Leishmania braziliensis | 79% | 100% |
A4IC72 | Leishmania infantum | 92% | 100% |
E9B723 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |